IL133643A0 - Therapeutic method for management of diabetes mellitus - Google Patents

Therapeutic method for management of diabetes mellitus

Info

Publication number
IL133643A0
IL133643A0 IL13364398A IL13364398A IL133643A0 IL 133643 A0 IL133643 A0 IL 133643A0 IL 13364398 A IL13364398 A IL 13364398A IL 13364398 A IL13364398 A IL 13364398A IL 133643 A0 IL133643 A0 IL 133643A0
Authority
IL
Israel
Prior art keywords
management
diabetes mellitus
therapeutic method
therapeutic
mellitus
Prior art date
Application number
IL13364398A
Other languages
English (en)
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of IL133643A0 publication Critical patent/IL133643A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13364398A 1997-06-23 1998-04-08 Therapeutic method for management of diabetes mellitus IL133643A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/880,945 US5929055A (en) 1997-06-23 1997-06-23 Therapeutic method for management of diabetes mellitus
PCT/US1998/006927 WO1998058658A1 (en) 1997-06-23 1998-04-08 Therapeutic method for management of diabetes mellitus

Publications (1)

Publication Number Publication Date
IL133643A0 true IL133643A0 (en) 2001-04-30

Family

ID=25377455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13364398A IL133643A0 (en) 1997-06-23 1998-04-08 Therapeutic method for management of diabetes mellitus

Country Status (9)

Country Link
US (1) US5929055A (enExample)
EP (1) EP1017414A4 (enExample)
JP (1) JP2002511864A (enExample)
KR (1) KR20010020497A (enExample)
AU (1) AU744846B2 (enExample)
CA (1) CA2294169A1 (enExample)
IL (1) IL133643A0 (enExample)
MX (1) MXPA99011821A (enExample)
WO (1) WO1998058658A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9902721A2 (hu) * 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
CA2343038A1 (en) * 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
WO2002072146A2 (en) * 2001-03-12 2002-09-19 Novartis Ag Combination of nateglinide or repaglinide with at least one further antidiabetic compound
US20040115261A1 (en) * 2001-04-05 2004-06-17 Ashley Robert A. Controlled delivery of tetracycline compounds and tetracycline derivatives
FR2826278B1 (fr) * 2001-06-20 2005-03-25 Lipha Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
ES2275889T3 (es) * 2001-06-20 2007-06-16 Merck Sante Utilizacion de agentes antidiabeticos para fabricar un medicamento que tiene un efecto cicatrizante.
EP2332547A1 (en) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease
WO2003059253A2 (en) * 2001-12-21 2003-07-24 Smithkline Beecham Corporation Compositions and methods for altering glucose production
EP2311796A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
WO2003075857A2 (en) 2002-03-08 2003-09-18 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
EA200401232A1 (ru) 2002-03-21 2005-12-29 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
KR101089429B1 (ko) 2002-07-12 2011-12-07 파라테크 파마슈티컬스, 인크. 3, 10, 및 12ａ 치환된 테트라시클린 화합물
WO2004091483A2 (en) 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
KR101228706B1 (ko) 2003-07-09 2013-02-01 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
EP1656341A1 (en) 2003-07-09 2006-05-17 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP1716101A1 (en) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
CA2585418A1 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2269978A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
US20070098763A1 (en) * 2005-10-11 2007-05-03 Sinnott Robert A Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
CA2673486C (en) * 2006-12-21 2015-09-08 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP3045449A1 (en) 2006-12-21 2016-07-20 Paratek Pharmaceuticals, Inc. Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
EA201070048A1 (ru) * 2007-07-06 2010-10-29 Паратек Фармасьютикалс, Инк. Способы синтеза замещённых соединений тетрациклина (варианты)
TWI585071B (zh) 2008-05-19 2017-06-01 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
PL3000805T3 (pl) 2008-08-08 2018-04-30 Tetraphase Pharmaceuticals, Inc. C7-fluoro podstawione związki tetracyklinowe
ES2627772T3 (es) 2009-05-08 2017-07-31 Tetraphase Pharmaceuticals, Inc. Compuestos de tetraciclina
WO2011025982A2 (en) 2009-08-28 2011-03-03 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
ES2621409T3 (es) 2010-03-31 2017-07-04 Tetraphase Pharmaceuticals, Inc. Compuestos policíclicos de tetraciclina
AU2013308504B2 (en) 2012-08-31 2016-11-10 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP6989262B2 (ja) 2014-10-27 2022-01-05 アセコー インコーポレイテッド 皮下外来患者管理
AU2016308953B2 (en) 2015-08-20 2020-09-10 Glytec, Llc Diabetes management therapy advisor
KR102880712B1 (ko) 2016-10-19 2025-11-03 테트라페이즈 파마슈티컬스, 인코포레이티드 에라바사이클린의 결정질 형태
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof
KR20220098682A (ko) 2019-05-14 2022-07-12 타임, 인크. 암을 치료하기 위한 조성물 및 방법
WO2021207487A1 (en) * 2020-04-08 2021-10-14 Hoffman Technologies Llc Methods of treating conditions characterized by insulin deficiency in animals
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985005036A1 (en) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
US5045538A (en) * 1990-06-28 1991-09-03 The Research Foundation Of State University Of New York Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
CA2103189C (en) * 1992-11-17 2005-05-03 Lorne M. Golub Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes
WO1995013805A1 (en) * 1993-11-17 1995-05-26 Duke University Medical Center Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
CA2217652A1 (en) * 1995-04-07 1996-10-10 Albert Einstein College Of Medicine Of Yeshiva University Recombinant .beta.-cell and uses thereof

Also Published As

Publication number Publication date
EP1017414A4 (en) 2004-10-06
WO1998058658A1 (en) 1998-12-30
JP2002511864A (ja) 2002-04-16
US5929055A (en) 1999-07-27
AU6889998A (en) 1999-01-04
CA2294169A1 (en) 1998-12-30
AU744846B2 (en) 2002-03-07
KR20010020497A (ko) 2001-03-15
MXPA99011821A (es) 2002-07-02
EP1017414A1 (en) 2000-07-12

Similar Documents

Publication Publication Date Title
IL133643A0 (en) Therapeutic method for management of diabetes mellitus
ZA983176B (en) Therapeutic compounds
EP0879279A4 (en) DIABETE TREATMENT
IL137105A0 (en) Method for administering aspb28-human insulin
ZA981343B (en) Sulfonylurea-glitazone combinations for diabetes
IL122718A0 (en) Methods for treating diabetes
FI971420L (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
HUP0002062A3 (en) Method for diagnosing bone dysbolism
SG44926A1 (en) Therapeutic heterocyclic compounds
AU1673297A (en) Therapeutic agent for diabetes
ZA958608B (en) Method of treating diabetes mellitus using kgf
GB9719161D0 (en) New therapeutic method
AU7718398A (en) Apparatus for positioning patients
GB9716345D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
AU2440599A (en) Therapeutic agent for complication of diabetes
EP1042004A4 (en) METHOD FOR TISSUE PERFUSION
GB9719189D0 (en) New therapeutic method
GB9719176D0 (en) New therapeutic method
GB2304046B (en) Diabetes therapy
GB9515060D0 (en) Therapeutic heterocyclic compounds
GB9719167D0 (en) New therapeutic method
GB9719166D0 (en) New therapeutic method
AUPO878097A0 (en) Treatment for diabetes